Thursday, February 12, 2015
Independent Research Report Highlights VGTI Florida’s Significant Economic Impact on Port St. Lucie and St. Lucie County

The report, prepared by Policom Corporation, also forecasts the Institute’s future economic impact and the potential for the City and County to develop a dynamic life science cluster in the region. ..

Read More
Tuesday, November 18, 2014
VGTI Florida to Collaborate with TapImmune to Advance Targeted Breast and Ovarian Cancer Vaccines into Phase II Clinical Trials

These highly promising therapeutic cancer vaccine candidates were developed by VGTI Florida’s Director of Cancer Vaccines and Immune Therapies Program, Keith Knutson, Ph.D. The goal is to prevent breast and ovarian cancer recurrence for patients who achieve remissions following standard-of-care treatment.  ..

Read More
Thursday, October 23, 2014
VGTI Florida to Participate in $10M NIH Contract to Develop New Vaccine Adjuvants

VGTI Florida and others will collaborate with OHSU as major sub-contractors to develop new vaccine adjuvants that could boost the effectiveness of a wide range of human vaccines for infectious diseases including West Nile Virus, Dengue and Japanese Encephalitis. ..

Read More
Sunday, October 12, 2014
VGTI Florida Launches the Center for Diseases of Aging

VGTI Florida, a leading, non-profit biomedical research institute, announced the launch of its Center for Diseases of Aging (“CDA”), a major initiative to accelerate the discovery and advancement of novel, best-in-class healthcare interventions for the prevention and treatment of diseases commonly associated with aging.  ..

Read More
Monday, August 11, 2014
VGTI Florida Aims to Stop Spread of Chikungunya Virus with Novel Vaccine

While there is currently no FDA-approved vaccine to prevent the spread of the chikungunya virus, the head of viral immunity research at the Vaccine & Gene Therapy Institute of Florida has developed a new platform vaccine technology that is expected to provide complete protection against chikungunya virus infection. ..

Read More
Monday, July 28, 2014
VGTI Florida Researcher Invents Potential Breakthrough Antiviral Compounds for Prevention of Mosquito-Borne Illnesses

VGTI Florida has filed a new patent application covering an invention that includes potent anti-viral compounds that are strong promoters of immunity in pre-clinical studies and are able to target a broad range of viral indications, including chikungunya and dengue. ..

Read More
Friday, February 07, 2014
VGTI Florida Scientists Awarded 3.8MM NIH Grant For HIV Research

A team of scientists from the Vaccine & Gene Therapy Institute (VGTI Florida) has recently been awarded a sizeable five-year grant from the National Institutes of Health (NIH) to study newly HIV infected patient’s earliest immune response to antiretroviral therapy (ART) before the virus causes damage to the patient’s immune system. ..

Read More
Tuesday, October 08, 2013
VGTI Florida’s Dr. Ted Ross Awarded a $2 Million NIH Sub-Award for Influenza Study

VGTI Florida is proud to announce Ted Ross, Ph. D., Program Director of Vaccines and Viral Immunity was awarded a $2 million sub-award grant from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to study immune and genetic responses to influenza as we age. ..

Read More
Thursday, October 03, 2013
Treasure Coast researcher works to develop vaccine to prevent breast cancer recurrence

The challenge in creating a cancer vaccine comes from cancer’s lack of a traditional vaccine target, such as a bacterium or virus. Instead, Dr. Knutson is working to develop a vaccine that targets a protein produced by breast tumors. His research centers on preventing cancer recurrence in patients who have been treated.  ..

Read More
Monday, August 12, 2013
VGTI researcher sets sights on injected cancer cure

Cancer researcher Richard Jove dreams of the day when cancer can be cured with a vaccination — a shot that would show the immune system how to find cancer cells and kill them. Such a simple solution is still years away, but Jove says it’s one of his goals as he takes over operations of the Vaccine and Gene Therapy Institute Florida, a nonprofit lab in Port St. Lucie. ..

Read More